Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Change of Subfoveal Choroidal Thickness After Intravitreal Injection of Ranibizumab and Its Correlation With Visual Acuity in Diabetic Retinopathy

NCT06173245 is registered in ClinicalTrials.gov with Egyptian Biomedical Research Network as lead sponsor.

NCT NCT06173245
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06173245 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Change of Subfoveal Choroidal Thickness After Intravitreal Injection of Ranibizumab and Its Correlation With Visual Acuity in Diabetic Retinopathy
Lead sponsor
Egyptian Biomedical Research Network
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2021
Completion date
February 1, 2023
Enrollment
50 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic retinopathy, intravitreal, ranibizumab, subfoveal choroidal thickness, visual acuity